Kestra Medical Technologies, Ltd. (KMTS) Misses Q4 EPS by 7c

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q4 EPS of ($0.64), $0.07 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $22.6 million, versus $21 million estimate.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• Advasa Holdings lists on Nasdaq under ticker ADBT
• Akeso's ivonescimab beats durvalumab in biliary tract cancer trial